Vertebral Body Augmentation Systems Comprising Microbubbles
US-2015374879-A1 · Dec 31, 2015 · US
US2024091417A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2024091417-A1 |
| Application number | US-202017768033-A |
| Country | US |
| Kind code | A1 |
| Filing date | Oct 13, 2020 |
| Priority date | Oct 14, 2019 |
| Publication date | Mar 21, 2024 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Anti-staining hydration mediums for medical products and packaged medical products containing the same.
Opening claim text (preview).
What is claimed is: 1 . A hydration medium for hydrating medical devices, comprising: a monomeric polyol(s) in an amount of between about 1 wt % and about 10 wt %; a surfactant(s) in an amount between about 0.01 wt % and about 10 wt %; hydration liquid being the balance of the hydration medium; and wherein a viscosity of the hydration medium is at most about 10 cP, and a surface tension of the hydration medium is at most about 65 mN/m. 2 . The hydration medium of claim 1 , wherein the viscosity of the hydration medium is between about 1 cP and about 9 cP. 3 . The hydration medium of claim 1 , wherein surface tension of the hydration medium is at most about 45 mN/m. 4 . The hydration medium of claim 1 , wherein the surface tension of the hydration medium is between about 45 mN/m and about 65 mN/m. 5 . The hydration medium of claim 1 , wherein the monomeric polyol(s) comprise one or more of glycerol, erythritol, ethylene glycol, diethylene glycol, propylene glycol, 1-4 butanediol and sucrose. 6 . The hydration medium of claim 1 , wherein the surfactant(s) comprises one or more of an anionic, non-ionic, cationic and amphoteric surfactant. 7 . The hydration medium of claim 1 , wherein the hydration medium comprises water. 8 . The hydration medium of claim 1 , wherein the hydration medium comprises saline. 9 . The hydration medium of claim 1 , further comprising additional agents. 10 . A packaged medical product, comprising: a medical product; a hydration medium comprising: a monomeric polyol(s) in an amount of between about 1 wt % and about 10 wt %; a surfactant(s) in an amount between about 0.01 wt % and about 10 wt %; hydration liquid being the balance of the hydration medium; and wherein a viscosity of the hydration medium is at most about 10 cP, and a surface tension of the hydration medium is at most about 65 mN/m. 11 . The packaged medical product of claim 10 , wherein the medical product comprises a hydrophilic intermittent urinary catheter. 12 . The packaged medical product of claim 10 , wherein the viscosity of the hydration medium is between about 1 cP and about 9 cP. 13 . The packaged medical product of claim 10 , wherein surface tension of the hydration medium is at most about 45 mN/m. 14 . The packaged medical product of claim 10 , wherein the surface tension of the hydration medium is between about 45 mN/m and about 65 mN/m. 15 . The packaged medical product of claim 10 , wherein the monomeric polyol(s) comprise one or more of glycerol, erythritol, ethylene glycol, diethylene glycol, propylene glycol, 1-4 butanediol and sucrose. 16 . The packaged medical product of claim 10 , wherein the surfactant(s) comprises one or more of an anionic, non-ionic, cationic and amphoteric surfactant. 17 . The packaged medical product of claim 10 , wherein the hydration medium comprises water. 18 . The packaged medical product of claim 10 , wherein the hydration medium comprises saline. 19 . The packaged medical product of claim 10 , further comprising additional agents.
Materials characterised by their function or physical properties {, e.g. lubricating compositions} · CPC title
Inorganic materials · CPC title
Materials for lubricating medical devices · CPC title
Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title
Packages specially adapted therefor (combined with means for introducing catheters, e.g. dispensers, A61M25/0113); catheter kit packages (for surgical articles A61B50/30) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.